- . Multiple drugs. Reactions Weekly 2024;2017:306

- Serena Zaltron, Anna Cambianica, Marco Di Gregorio, Cosimo Colangelo, Samuele Storti, Giorgio Tiecco, Francesco Castelli, Eugenia Quiros-Roldan. Case report: An occult hepatitis B virus infection reactivation in an HIV/HCV coinfected patient during an immune reconstitution inflammatory syndrome. Front. Cell. Infect. Microbiol. 2023;13

- Stamatia Katelani, George E Fragoulis, Athanasios-Dimitrios Bakasis, Abraham Pouliakis, Elena Nikiphorou, Fabiola Atzeni, Theodoros Androutsakos. HBV reactivation in patients with rheumatoid arthritis treated with anti-interleukin-6: a systematic review and meta-analysis. 2023;62:SI252

- Galina I. Gridneva, Boris S. Belov, Evgeniia S. Aronova. Chronic hepatitis B in rheumatic diseases: issues of screening and reactivation of infection: A review. Terapevticheskii arkhiv 2024;96:523

- Esra Erdoğan, Mehmet Ali Erdogan, Servet Yolbaş, Muhammed Furkan Keser, Saliha Aydın. ÇÖZÜLMÜŞ HEPATİT B ENFEKSİYONLU VE ROMATİZMAL HASTALIĞI OLAN BİREYLERDE RİTUKSİMAB KULLANIMININ HEPATİT B REAKTİVASYONU ÜZERİNE ETKİSİ: TEK MERKEZLİ BİR ÇALIŞMA. 2024;12:692

- Chien-Hao Su, Chung-Yu Chen, Chien-Ting Liu, Yi-Hsin Yang, Pao-Chu Wu. Hepatitis and Hepatitis B Virus Reactivation in Everolimus-Treated Solid Tumor Patients: A Focus on HBV-Endemic Areas. Cancers 2024;16:3997

- Kuan‐Chu Hou, Tung‐Hung Su, Chien‐Neng Kao, Huei‐Ru Cheng, Tai‐Chung Tseng, Chun‐Jen Liu, Song‐Chou Hsieh, Jia‐Horng Kao. Rituximab carries high risks of hepatitis B virus reactivation in hematologic and rheumatic patients with chronic or resolved hepatitis B. J of Gastro and Hepatol 2024;39:2447
